Receiving a diagnosis for a serious condition like Cutaneous T-Cell Lymphoma (CTCL) is a life-altering event. The confusion, fear, and uncertainty can be heart-wrenching, especially when you learn that the medication you trusted to help you may be linked to your illness. 

If you were prescribed Dupixent for an inflammatory condition and were later diagnosed with CTCL, please know you have the right to seek answers. The experienced and compassionate Dupixent Cutaneous T-Cell Lymphoma (CTCL) lawsuit attorneys at Stark & Stark are here to help you understand your options and guide you toward justice and accountability.

For over 90 years, our firm has been a pillar of support for individuals and families throughout New Jersey and Pennsylvania. We understand the physical, emotional, and financial burdens that a serious medical diagnosis can place on your life. Our commitment is to listen to your story with empathy and provide the dedicated legal support you need during this challenging time.

Key Takeaways about Dupixent CTCL Lawsuits

• The medication Dupixent (dupilumab), used to treat eczema and other inflammatory conditions, has been linked in some studies to an increased risk of developing Cutaneous T-Cell Lymphoma (CTCL).
• CTCL is a type of non-Hodgkin lymphoma, with common forms including mycosis fungoides and Sezary Syndrome.
• The symptoms of early-stage CTCL can closely resemble eczema, potentially leading to a dangerous delay in diagnosis for patients taking Dupixent.
• Lawsuits allege that the manufacturers of Dupixent, Regeneron and Sanofi, did not provide adequate warnings to patients and doctors about this potential risk.
• Patients diagnosed with CTCL after using Dupixent may be able to pursue compensation through a product liability lawsuit.

Why Choose Stark & Stark for Your Dupixent Claim?

When you are facing a legal challenge against a major pharmaceutical company, you need a law firm with a deep history of advocacy and the resources to stand up for your rights. Since 1933, Stark & Stark has built its reputation on a foundation of integrity, unwavering client commitment, and a personal approach to every case. We aren’t just your attorneys; we are your partners, dedicated to helping you through this difficult journey.

Here are a few reasons why families trust Stark & Stark:

• A Legacy of Trust: For over 90 years, we have been a constant legal resource for the people of New Jersey and Pennsylvania. Our longevity is a testament to the relationships we build and the results we achieve.
• Compassionate and Dedicated Advocacy: We understand the stress you are under. Our team is committed to handling the legal complexities of your case so you can focus on your health and your family. We listen first, then act decisively on your behalf.
• Comprehensive Resources: Taking on a large drug manufacturer requires significant resources. Our firm has the financial stability, technological infrastructure, and experienced support staff needed to thoroughly investigate your claim and build a powerful case.

We believe in putting the law to work for you, providing practical solutions and steadfast support every step of the way. Contact us today to discuss your case during a free, no-obligation consultation. 

Understanding Dupixent and Its Approved Uses

Dupixent, known by the generic name dupilumab, is a biologic medication administered by injection. It was developed by the pharmaceutical companies Regeneron and Sanofi as a new approach to treating certain inflammatory conditions. Instead of suppressing the entire immune system like traditional steroids, Dupixent works by targeting and blocking two specific proteins, interleukin 4 (IL-4) and interleukin 13 (IL-13), which are key drivers of a particular type of inflammation in the body.

The U.S. Food and Drug Administration (FDA) first gave its approval for Dupixent in March 2017, primarily for treating moderate-to-severe eczema (atopic dermatitis). Its success in managing this condition led to the expansion of its approved uses.

Today, Dupixent is prescribed for a range of conditions, including:

• Asthma
• Eosinophilic esophagitis (EoE), an inflammatory condition of the esophagus
• Chronic rhinosinusitis with nasal polyps (CRSwNP)
• Prurigo nodularis, a skin disease causing hard, itchy lumps
• Bullous pemphigoid, a rare skin condition causing large blisters
• Chronic obstructive pulmonary disease (COPD)

For many patients, Dupixent was presented as a breakthrough treatment. However, emerging information has raised serious concerns about potentially undisclosed and life-threatening side effects.

The Alarming Link Between Dupixent and Cutaneous T-Cell Lymphoma (CTCL)

Recent medical research and patient reports have begun to uncover a deeply troubling potential connection between the use of Dupixent and the development of Cutaneous T-Cell Lymphoma (CTCL). This is not a minor side effect; CTCL is a form of non-Hodgkin lymphoma, a type of cancer that begins in the white blood cells (T-lymphocytes) and primarily affects the skin.

The concerns are not just based on isolated reports but are supported by emerging scientific evidence. A 2024 study in the Journal of the American Academy of Dermatology and another 2025 study in the Journal of Allergy and Clinical Immunology both found that patients using Dupixent were significantly more likely to develop CTCL than individuals who did not use the drug. These alarming findings have also prompted an ongoing investigation by the FDA into Dupixent and these dangerous side effects, highlighting the seriousness of the potential risk.

The most common types of CTCL include:

• Mycosis Fungoides: This is the most prevalent form of CTCL, often starting as a rash or patch of skin that can be mistaken for eczema, psoriasis, or dermatitis. Over time, it can progress to form thicker plaques or tumors.
• Sézary Syndrome: This is a more aggressive and rare form of CTCL that affects the skin across the entire body and is also found in the blood. It causes widespread, intensely itchy, red skin and can impact the lymph nodes.

The core of the legal claims against Regeneron and Sanofi is the allegation that these companies failed in their duty to warn patients and the medical community about the potential risk of developing CTCL. 

Patients have a right to be fully informed of the risks associated with any medication before they decide to take it. When a manufacturer fails to provide adequate warnings, they can be held accountable for the harm that results. 

According to the National Institutes of Health, an accurate diagnosis leads to effective treatment, and anything that obscures or delays this process is a serious concern.

The Danger of a Delayed CTCL Diagnosis

One of the most tragic aspects of the link between Dupixent and CTCL is the potential for a delayed diagnosis. The early symptoms of mycosis fungoides—the most common form of CTCL—can look nearly identical to the eczema Dupixent is prescribed to treat. A patient might see skin rashes, patches, and itching.

This creates a dangerous scenario. A patient taking Dupixent might believe the medication is simply not working as well as it should be, or that they are having a minor flare-up of their eczema. Their doctor might also assume the symptoms are related to the underlying skin condition rather than a new, far more serious disease. This confusion can cause a critical delay in performing the biopsies and tests needed to diagnose CTCL correctly.

When cancer is not diagnosed in its early stages, it can progress, becoming more difficult to treat and potentially spreading to lymph nodes or other organs. Patients who placed their trust in Dupixent to improve their quality of life may have unknowingly been masking the symptoms of cancer, losing precious time that could have been used for effective treatment. This delay can have devastating consequences for a person’s prognosis and overall health.

Holding Drug Manufacturers Accountable for Failing to Warn

In the United States, pharmaceutical companies have a legal and ethical responsibility to ensure their products are reasonably safe for consumers. This includes a duty to provide clear, comprehensive, and accurate warnings about all known or knowable risks and side effects. When they fail in this duty, they can be held liable through a legal action known as a product liability lawsuit.

A lawsuit centered on a dangerous drug like Dupixent is not just about money; it is about accountability. It is about sending a message that patient safety must always come before profits. The legal process is designed to give a voice to those who have been harmed and to hold powerful corporations responsible for their actions.

The attorneys at Stark & Stark have extensive experience handling complex personal injury and product liability cases. We meticulously investigate every claim, gathering evidence, consulting with medical professionals, and building a case designed to demonstrate how a manufacturer’s negligence led to our client’s suffering. From the busy streets of Philadelphia to the quiet neighborhoods of Marlton, our team is prepared to stand up for the rights of those injured by unsafe medications.

What Compensation Could Be Available in a Dupixent CTCL Lawsuit?

If you or a loved one was diagnosed with Cutaneous T-Cell Lymphoma after taking Dupixent, filing a lawsuit may allow you to recover compensation for the immense damages you have suffered. This compensation, legally referred to as “damages,” is intended to help restore you to the financial position you were in before your diagnosis and to compensate for your non-economic suffering.

While every case is unique, potential compensation may cover:

• Medical Expenses: This includes all costs related to your CTCL diagnosis and treatment, such as hospital stays, doctor visits, chemotherapy, radiation, medication, and any future medical care you may require.
• Lost Wages and Loss of Earning Capacity: If your illness or treatment has forced you to miss work or has prevented you from returning to your job, you may be compensated for the income you have lost and the wages you are likely to lose in the future.
• Pain and Suffering: This is compensation for the significant physical pain, emotional distress, and mental anguish caused by your cancer diagnosis and treatment. It also covers the loss of enjoyment of life—the inability to participate in hobbies, activities, and relationships as you once did.
• Punitive Damages: In some cases, a court may award punitive damages. These are not meant to compensate the victim but rather to punish the manufacturer for particularly reckless or egregious behavior and to deter other companies from acting similarly in the future.

This financial recovery can provide crucial stability for your family, allowing you to focus on what matters most: your health and well-being.

How a Lawyer Can Help with Your Dupixent Cutaneous T-Cell Lymphoma (CTCL) Lawsuit 

Handling a legal claim while dealing with a serious health condition can feel impossible. A dedicated attorney can lift that burden from your shoulders and manage every aspect of your case. At Stark & Stark, we believe our role is to be your guide and your advocate, fighting for you every step of the way.

When you work with our firm, our legal team will immediately get to work by:

• Conducting a Thorough Investigation: We will gather all of your medical records, pharmacy prescriptions, and other documents to establish a clear timeline of your Dupixent use and your CTCL diagnosis.
• Consulting with Medical Professionals: We work with a network of respected medical professionals who can review your case and provide testimony linking your cancer to the medication.
• Handling All Legal and Insurance Communications: We will take over all communication with the drug manufacturer’s defense attorneys and insurance companies, protecting you from their tactics and ensuring your rights are preserved.
• Building and Filing Your Claim: We will meticulously prepare and file all necessary legal documents to initiate your lawsuit, making sure to meet all deadlines and procedural requirements.
• Fighting for a Fair Settlement or Verdict: Our attorneys are skilled negotiators and accomplished trial lawyers. We will work to secure a full and fair settlement on your behalf, but we are always prepared to take your case to trial if that’s what it takes to achieve justice.

From your first free consultation until the final resolution of your case, our team will be there to answer your questions and provide the support you deserve.

Dupixent Lymphoma Lawsuit FAQs

We have compiled these answers to common questions to help you better understand your situation.

How much does it cost to hire an attorney for a Dupixent lawsuit?

At Stark & Stark, we handle these cases on a contingency fee basis. This means you pay absolutely no upfront fees. We only get paid if we successfully recover compensation for you through a settlement or a court verdict. This allows everyone to have access to high-quality legal representation, regardless of their financial situation.

How long do I have to file a lawsuit for an injury caused by a drug?

Every state has a law called a “statute of limitations,” which sets a strict deadline for filing a lawsuit. In personal injury and product liability cases, this clock usually starts running from the date you discovered or reasonably should have discovered your injury and its potential cause. These deadlines can be complex, so it is crucial to speak with an attorney as soon as possible to protect your right to file a claim.

What should I do if I am currently taking Dupixent and am worried?

Your health is the top priority. We cannot provide medical advice, and you should never stop taking a prescribed medication without first consulting your doctor. Discuss your concerns about the potential risks with your physician. They can help you weigh the benefits and risks and determine the best course of action for your specific medical needs.

What kind of evidence is needed to build a strong case?

A successful case requires strong evidence. This typically includes your medical records detailing your CTCL diagnosis, pathology reports confirming the type of cancer, prescription records showing your history of Dupixent use, and testimony from medical professionals. Our legal team will handle the process of gathering all this crucial evidence for you.

Will my case definitely go to trial in court?

Many product liability cases are resolved through a settlement before they ever reach a courtroom. A settlement is a negotiated agreement between you and the defendant (the drug manufacturer). However, if the manufacturer is unwilling to offer a fair and just settlement, our attorneys are fully prepared to present your case to a judge and jury to fight for the compensation you deserve.

What if I’m not sure if Dupixent is what caused my CTCL?

It is completely normal to have this uncertainty. It is not your job to prove the connection—that is our job. We will conduct a free, in-depth evaluation of your situation to help determine if you may have a valid claim. If we believe there is a strong basis to proceed, we will use our resources and consult with medical professionals to build the connection.

Contact a Trusted Dupixent Lawyer at Stark & Stark Today 

If you or a family member used Dupixent and were subsequently diagnosed with cutaneous T-cell lymphoma, mycosis fungoides, or Sézary Syndrome, you deserve to know your legal rights. The immense physical and emotional pain of a cancer diagnosis should not be compounded by financial hardship.

The Dupixent lawsuit attorneys at Stark & Stark are here to offer the guidance and advocacy you need. With a legacy of over 90 years of service to communities in New Jersey and Pennsylvania, we have the experience, resources, and dedication to stand up to large pharmaceutical companies on your behalf.

Contact us today at (800) 535-3425 or through our online form for a free, no-obligation consultation to discuss your case. Let us handle the legal fight so you can concentrate on your health.